Columbia Northwest Pharmaceuticals Report issue

For profit Phase 2
Founded: Bellevue WA United States (2009)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2010
NCT01189812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Columbia Northwest Pharmaceuticals, LLC

Active Ingredients

Drugs in Phase 2 Trials (3)

carvedilol (coreg) (1 trial)

citalopram (celexa) (1 trial)

lithium (lithonate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Borderline Personality Disorder (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Disease (Phase 2)

Mood Disorders (Phase 2)

Personality Disorders (Phase 2)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3